The Investigators propose a multi-center, observational, longitudinal, cohort study of the serology and wellness of HCWs over a year of the COVID-19 pandemic.
All consenting participants will undergo survey assessment and diagnostic testing with the Abbott Architect SARS-CoV-2 IgG assay (IgG) every three months for a one year period. Clinical outcomes and related data capture will be performed at this same interval.
Study Type
OBSERVATIONAL
Enrollment
2,000
Chandler Regional Medical Center
Chandler, Arizona, United States
RECRUITINGBaseline IgG Assay Information
Seroprevalence of anti-SARS-CoV-2 IgG antibodies in HCWs
Time frame: Baseline
Change in IgG Assay Information
The change in the seroprevalence of anti-SARS-CoV-2 IgG antibodies in HCWs over one year.
Time frame: From Baseline to 3 months, 6 months, 9 months, & 12 months
Compare seroprevalence of anti-SARS-CoV-2 IgG antibodies between groups
Compare seroprevalence of anti-SARS-CoV-2 IgG antibodies in 'front-line' workers and non-'front-line' HCWs
Time frame: From Baseline to 3 months, 6 months, 9 months, & 12 months
Impact of COVID-19 Pandemic on Perceived Wellness and Job Satisfaction
Over the 12 months of the study, evaluate the impact of the COVID-19 pandemic on HCW wellness using the Perceived Wellness Survey. Job satisfaction will be measured using a locally developed questionnaire.
Time frame: Baseline to 12 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.